Development of Dose Conversion Coefficients for Radionuclides Produced in Spallation Neutron Sources by Patton, Phillip W.
Transmutation Sciences Physics (TRP) Transmutation Research Program Projects 
8-11-2011 
Development of Dose Conversion Coefficients for Radionuclides 
Produced in Spallation Neutron Sources 
Phillip W. Patton 
University of Nevada, Las Vegas 
Follow this and additional works at: https://digitalscholarship.unlv.edu/hrc_trp_sciences_physics 
 Part of the Health and Medical Physics Commons, and the Nuclear Commons 
Repository Citation 
Patton, P. W. (2011). Development of Dose Conversion Coefficients for Radionuclides Produced in 
Spallation Neutron Sources. 
Available at: https://digitalscholarship.unlv.edu/hrc_trp_sciences_physics/12 
This Grant is protected by copyright and/or related rights. It has been brought to you by Digital Scholarship@UNLV 
with permission from the rights-holder(s). You are free to use this Grant in any way that is permitted by the 
copyright and related rights legislation that applies to your use. For other uses you need to obtain permission from 
the rights-holder(s) directly, unless additional rights are indicated by a Creative Commons license in the record and/
or on the work itself. 
 
This Grant has been accepted for inclusion in Transmutation Sciences Physics (TRP) by an authorized 
administrator of Digital Scholarship@UNLV. For more information, please contact digitalscholarship@unlv.edu. 
Project Title: 
 
Development of Dose Conversion Coefficients for Radionuclides Produced in Spallation 
Neutron Sources  
 
August 11, 2001 
 
Principal Investigator: Phillip W. Patton 
    Assistant Professor 
Department of Health Physics 
    University of Las Vegas Nevada 
    4505 Maryland Parkway, Las Vegas NV 89154-3037 
    Tel:  (702) 895-3555 
    Fax: (702) 895-4819     
Email:  phillip.patton@ccmail.nevada.edu 
 
Co-Principal Investigator: Mark J. Rudin 
    Chair, Associate Professor 
Department of Health Physics 
    University of Las Vegas Nevada 
    4505 Maryland Parkway, Las Vegas NV 89154-3037 
    Phone:  (702) 895-3299 
    Fax: (702) 895-4819 
    Email:  mrudin@ccmail.nevada.edu  
 
Collaborators (Proposed): Faculty and Graduate Students 
    Idaho State University 
    Georgia Institute of Technology 
    Texas A&M University 
    University of Florida 
    University of Tennessee 
 
Collaborators (DOE): Brent J. Boyack 
    Tony Andrade 
    AAA Project Leader for NEPA/Safety 
    P.O. Box 1663, MS K575 
    Los Alamos, NM 87545 
    Tel: (505) 667-2023 
    Fax: (505) 665-2897 
    Email: bboyack@lanl.gov 
 
AAA Research Area: Systems Integration:  Safety/Dosimetry 
 
Year 1 (September 1, 2001 – August 31, 2002) Funding Request:  $160,000 
Year 2 - $160,000 




A research consortium comprised of representatives from several universities and national 
laboratories will be established as part of this project to generate internal and external dose 
conversion coefficients for radionuclides produced in spallation neutron sources.  Information 
obtained from this multi-year study will be used to support the siting and licensing of future 
accelerator-driven nuclear initiatives within the U.S. Department of Energy complex, including 
the Spallation Neutron Source (SNS) and Accelerator Production of Tritium (APT) projects.  
Determination of these coefficients will also fill data gaps for several hundred radionuclides that 
exist in Federal Guidance Report (FGR) No. 11 and in Publications 68 and 72 of the 
International Commission on Radiological Protection (ICRP).  This proposal discusses the 
overall research collaboration in general and the University of Nevada, Las Vegas (UNLV) 
funded portion of the research to be implemented by Phillip Patton and Mark Rudin in particular. 
 
Background and Rationale 
 
The U.S. Department of Energy (DOE) was authorized by Congress in 2001 to create the 
Advanced Accelerator Applications (AAA) program to address pressing nuclear-related issues 
facing the nation such as nuclear energy and waste management concerns, declining U.S. nuclear 
infrastructure, global nuclear leadership, and national defense.  Besides investigating 
transmutation as a viable alternative of long-term waste management, the AAA program is 
continuing to develop the technology base of alternative tritium production options, including the 
completion of the APT design and development activities.  Other national and international 
accelerator programs such as the SNS project located at the Oak Ridge National Laboratory 
(ORNL) are expected to benefit from the knowledge and data obtained from research activities 
within the AAA program. 
 
The AAA program will need to assess the health risks associated with the operation of each of 
their accelerator-driven nuclear facilities for both NEPA and PSAR development.  Quantifying 
the radiological risks to workers will have to be addressed during the design and siting of each of 
these facilities.  U.S. Environmental Protection Agency (EPA) Federal Guidance Report No. 11 
“Limiting Values of Intake and Air Concentration and Dose Conversion Factors for Inhalation, 
Submersion, and Ingestion”, developed two derived guides, Annual Limit on Intake (ALI) and 
the Derived Air Concentration (DAC), to be used to control radiation exposure in the workplace.  
The ALI is the annual intake of a radionuclide which would result in a committed effective dose 
equivalent of 0.05 Sv/yr for stochastic effects, or a committed dose equivalent to an individual 
organ or tissue of 0.5 Sv/yr for deterministic effects, to Reference Man (ICRP 1975).  A DAC is 
that concentration of a radionuclide in air which, if breathed by Reference Man for a work-year, 
would result in an intake corresponding to its ALI (EPA 1988).  Therefore, ALIs and DACs can 
be used for assessing radiation doses due to accidental ingestion and inhalation of radionuclides 
and are used for limiting radionuclide intake through breathing of, or submersion in, 
contaminated air. 
 
In addition to determining ALIs and DACs, in many situations it is useful to know the committed 
dose equivalent to an organ or tissue per unit intake, the committed effective dose equivalent per 
unit intake, the dose equivalent rate per unit air concentration of radionuclide, or the effective 
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dose equivalent rate per unit air concentration of radionuclide.  These dose conversion 
coefficients (DCC) allow simple determination of radiation dose associated with various 
exposure scenarios, and ultimately, assessing the health risks to workers in a nuclear facility. 
 
Even though the ALIs, DACs, and DCCs calculated in Federal Guidance Report No. 11 adhere 
to the derived limits in Publication 30 (ICRP 1979), which incorporate current knowledge of 
radionuclide dosimetry and biological transport in humans, the report is not exhaustive in 
reference to anthropogenic radionuclides.  Unfortunately, many of the rare radionuclides 
produced during the spallation process are not addressed in current radiation protection 
standards.  There may be as many as 660 radionuclides that would be produced in either the 
target or blanket of the APT for which no data exists in FGR No. 11 or in Publications 68 and 72 
of the ICRP.  The number of radionuclides that need to be studied is expected to increase if those 
produced in the target and blanket from the Accelerator-Driven Test Facility (ADTF) and SNS 
activities are also considered. 
 
It is the intent of the current research to develop a methodology and generate internal and 
external dose conversion coefficients for radionuclides produced in spallation neutron sources.  
Results from this study will expand the ALI and DAC data of FGR No. 11 in order to include 




There are four research objectives for Year 1 of this project.  They are to: 
 
• Establish a research consortium comprised of representatives from several 
universities and national laboratories. 
• Develop a prioritized list of radionuclides produced during the spallation process 
that will be considered as part of the study. 
• Further Georgia Tech’s work on developing a reproducible methodology to 
determine internal and external DCC. 




Results from the proposed work will be invaluable to individuals and organizations responsible 
for ensuring the safety of their workers in accelerator facilities, and the national and international 
radiation safety profession in general.  The DCCs generated as part of this study can be used to 
support the siting and licensing of future accelerator-driven nuclear initiatives within the U.S. 
DOE complex, including the SNS and APT projects.  As mentioned previously, determination of 
these coefficients will also fill data gaps for approximately 600 radionuclides that exist in FGR 
No. 11 and in ICRP Publications 68 and 72. 
 
From a much larger perspective, the establishment of the multi-university/national laboratory 
consortium as part of this project will further enhance the technical infrastructure of the AAA 
program.  The proposed composition of the consortium would also appear to make it an excellent 
resource for radiation safety issues facing the AAA program in the future.  Finally, students 
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selected to participate on the project will have the opportunity to work with a number of leaders 
in the health physics community on this important activity. 
 
Research Approach 
      
Each of the above objectives will be accomplished through the completion of specific tasks.  
Tasks associated with each objective are identified below: 
 
Objective 1: Establish a research consortium comprised of representatives from several 
universities and national laboratories. 
 
The proposed work will draw upon the experience and expertise residing at a number of 
respected health physics academic programs across the United States and representatives from 
DOE national laboratories.  Faculty and students from the following academic institutions will 
initially be invited to participate in the consortium: Georgia Institute of Technology, Idaho State 
University, Texas A & M University, University of Florida, and the University of Nevada, Las 
Vegas (UNLV).  The following DOE national laboratories will also be invited:  Los Alamos 
National Laboratory (LANL) and Oak Ridge National Laboratory (ORNL).  There is every 
expectation that the number of academic institutions/national laboratories may grow as the 
project evolves. 
 
A Technical Advisory Group will be established to direct and oversee consortium activities.  The 
following individuals will be invited to serve on the Advisory Group: 
 
 Phillip Patton ,UNLV, Project Coordinator 
 Wesley Bolch, University of Florida 
 Brent Boyack, LANL  
Steve Chase, U.S. Department of Energy 
Keith Eckerman, ORNL 
 Nolan Hertel, Georgia Tech 
 John Poston, Texas A&M 
 
The Project Coordinator will be responsible for scheduling and hosting the initial meeting of the 
Technical Advisory Group.  The first meeting will be held in Las Vegas, NV, at the beginning of 
FY 02.  Items to be addressed during this meeting include, but are not limited to, further defining 
the scope of the consortium, outlining the roles and responsibilities of working group members 
to meet project research objectives, securing additional funding for participants, and scheduling 
additional meetings.  It should be emphasized that Advisory Group members and all participating 
members of the consortium will work collaboratively to complete all tasks associated with the 
project.  UNLV personnel will host future working group meetings periodically to continually 
encourage collaboration and ensure project activities are completed in a timely manner.  The 
current proposal requests funding for two UNLV graduate students, one undergraduate student, 
and summer salary for the Project Coordinator to support project activities.  
 
Objective 2:   Develop a prioritized list of radionuclides produced during the spallation process 
that will be considered as part of the study. 
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Due to the magnitude of the project, the Technical Advisory Group will work collectively to 
develop an exhaustive list of radionuclides that could potentially be created during the spallation 
process.  It is proposed that the list be divided into two major categories: radionuclides with half-
lives greater than ten minutes and those with half-lives less than ten minutes.  This is based upon 
the fact that ICRP models used to describe the behavior of radionuclides in the body are not valid 
for the intake of short-lived radionuclides (T1/2 < 10 min).  Subsequently, both internal and 
external DCCs will be calculated for radionuclides with T1/2 >10 min, while only external DCCs 
will be determined for the shorter half-life species.  Further ranking of radionuclides within each 
grouping with respect to the rate of biological elimination, organ of uptake, and other pertinent 
biological and metabolic data will be performed by the Technical Advisory Group at a later date.  
Radiological hazards associated with each nuclide cannot be used as initial sorting criteria due to 
the complicated decay scheme of the majority of the radionuclides. 
 
Objective 3:  Develop a reproducible methodology to determine internal and external DCC. 
 
The metabolic models and data from ICRP Publication 30, “Limits for Intakes of Radionuclides 
by Workers” will be applied in order to maintain consistency with current standards.  ICRP 
Publication 30 defines the committed dose equivalent in a target organ, T, from activity in a 
source organ, S, for each type of radiation, i, of a particular radionuclide, j, as: 
 
Sv      S)SEE(T    U10 x 1.6S)(TH is
10
iT 50, ←=←
−          Eq. 1 
 
where Us is the total number of transformations of radionuclide, j, in source organ, S, over 50 
years following intake of the radionuclide and SEE is the specific effective energy per gram for 
radiation type, i, absorbed in target organ, T, per transformation in source organ, S, modified by a 
quality factor.  For all types of radiation emitted by radionuclide j, Eq. 1 becomes: 
 











−     Eq. 2 
 
Therefore, the development of the DCCs involves determining Us and SEE(T←S) values.  For 
consistency with Federal Guidance Report No. 11, dose conversion coefficients will be evaluated 
for an adult male with the target tissues of gonads, breast, lung, red marrow, bone surface 
(endosteum), thyroid, remainder, and total committed effective dose equivalent. 
 
The first step in calculating the DCCs is to calculate the number of transformations per Bq in the 
source over 50 years.  This requires knowledge of the physical and metabolic data (i.e. 
radioactive half-live, inhalation class, and the fraction of stable element reaching the body fluids 
following ingesting) for each radionuclide.  For the gastrointestinal tract and lung system, 
transformations are calculated for up to two progeny.  In order to calculate the Us, the number of 
transformations in both the respiratory and gastrointestinal models must be calculated, as well as 
the activity transferred to the transfer compartment (i.e. blood).  In addition, the number of 
transformations over 50 years in each body tissue or organ to which activity is transferred must 
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also be calculated.  A Microsoft Excel spreadsheet will be developed to perform these 
calculations. 
 
The second step in determining DCCs is to calculate the SEE(T←S) values.  Computer codes 
have been developed at Oak Ridge National Laboratory’s Radiation Safety Information 
Computational Center to determine these values.  The primary code of interest is CCC-620: 
SEECAL 2.0, which evaluates the SEE(T←S) in target tissues or organs per unit activity residing 
in the source regions.  The type, energy, and frequency of the nuclide radiations, as well as 
progeny information, used in SEECAL are accessed from the DLC-172: NUCDECAY code.  
Within this code are two radionuclide databases, one that consists of the data on the radiations 
emitted by the 825 radionuclides reported in ICRP Publication 38, and one that consists of the 
242 radionuclides published in a MIRD monograph.  However, a majority of the radionuclides 
that will be produced by the AAA program’s potential spallation neutron sources are not 
included in either database.  Therefore, it is proposed that a third radionuclide database be 
developed, which contains decay data for nuclides of interest that are not included in the other 
two databases.  The nuclear decay data tabulated in this project would be available to ICRP Task 
Group on Dose Calculations for the planned revision of ICRP Publication 38. 
 
Two different approaches can be used to develop the aforementioned database.  The most 
straightforward approach would be to manually enter the decay data for each radionuclide 
obtained from the Evaluated Nuclear Structure Data File, maintained by Brookhaven National 
Laboratory.  The second method would be to use the PSR-191: EDISTR code developed at 
ORNL in order to calculate the mean energies and absolute intensities of all principal radiations 
associated with the radioactive decay of each nuclide.  In either case, the database will be 
referenced by the NUCDECAY and SEECAL programs in order to obtain the necessary 
SEE(T←S) values.  Note that ORNL has a collaborative effort underway under the auspices of 
the U.S. EPA, with the Japan Atomic Energy Research Institute (JAERI) for the processing of 
nuclear decay data through the EDISTR code.  It is expected that the present proposed work will 
tie in closely with that effort. 
  
Once both Us and SEE(T←S) values are calculated, the committed dose equivalent in a target 
organ, T, can be calculated using Eq. 2.  Furthermore, the committed effective dose equivalent 




T 50,TE H  wH           Eq. 3 
      
Once the committed dose equivalent to all target organs and the committed effective dose 
equivalent are determined, values of the ALI and DAC can be calculated for each radionuclide. 
 
Some preliminary work on developing a methodology to complete this work has already been 
initiated by individuals at Georgia Institute of Technology.  Nolan Hertel from this institution 
will be invited to share this methodology at early meetings of the technical working group.  
Group members will further develop the methodology so it can be used by all 
individuals/organizations working on the project.  It is expected that several members of the 
technical working group will provide valuable insight during the development and potential 
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modification of the methodology.  For example, Keith Eckerman of ORNL is a member of the 
ICRP’s Task Group on Dose Calculation and is leading the development of the DCAL code used 
to calculate internal and external DCCs.   
 
Objective 4:  Generate DCC values for selected radionuclides. 
 
The Technical Advisory Group will divide the list of radionuclides among the participating 
universities.  Faculty and students at these institutions will employ the methodology to determine 
DCCs for each of their assigned radionuclides.  A limited number of DCC values are expected to 
be generated the first fiscal year.  The remainder of the radionuclides will be completed in Years 




Year 1 Activities                 Completion Date 
 
Establish research consortium participation    September 2001 
 
Preliminary meeting of the Technical Advisory Group  October 2001 
(Subsequent meetings held bi-annually at a minimum) 
 
Complete prioritized list of radionuclides    December 2001  
 
Complete DCC methodology      March 2002 
 
Determine preliminary set of DCCs     September 2002 
 
Generate Annual Report      September 2002 
 
Year 2 Activities                 Completion Date 
 
Determine second set of DCCs     September 2003 
 
Generate Annual Report      September 2003 
 
 
Year 3 Activities                 Completion Date 
 
Determine third set of DCCs      September 2004 
 





The following deliverables will be completed during Year 1 of the project: 
 
DCC Methodology Report (April 30, 2002):  The principal investigator will generate a report 
describing the methodology developed by the Technical Advisory Group to calculate internal 
and external DCCs for radionuclides produced from spallation neutron sources.  The report will 
also include the prioritized list of radionuclides that will be considered in the study. 
 
Annual Report (September 30, 2002):  The principal investigator will generate an annual report 
that outlines project activities performed during FY 02.  The report will include preliminary 
DCC data generated for a number of radionuclides. 
 
Professional Meeting Presentations/Publications (September 30, 2002):  It is expected that the 
results of this study will be presented and/or published at selected professional meetings and in 
the scientific literature.  Abstracts or manuscripts generated as part of this study will be sent to 
the AAA/UNLV program for review. 
 
Annual Reports and any professional meeting presentations, technical publications, or student 
theses will also be developed and delivered to the AAA/UNLV program at the end of the FY 03 
and FY 04.   
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